Hossam Zaki to Asharq Al-Awsat: No Dialogue With Iran, Turkey Until They Stop Supporting Terrorism

Assistant Secretary-General of the Arab League Ambassador Hossam Zaki (Asharq Al-Awsat)
Assistant Secretary-General of the Arab League Ambassador Hossam Zaki (Asharq Al-Awsat)
TT

Hossam Zaki to Asharq Al-Awsat: No Dialogue With Iran, Turkey Until They Stop Supporting Terrorism

Assistant Secretary-General of the Arab League Ambassador Hossam Zaki (Asharq Al-Awsat)
Assistant Secretary-General of the Arab League Ambassador Hossam Zaki (Asharq Al-Awsat)

Assistant Secretary-General of the Arab League Ambassador Hossam Zaki said that Arab dialogue with Turkey and Iran would remain suspended until the two countries are ready to change their political approach by respecting states’ sovereignty and stopping their support of terrorism.

In an interview with Asharq Al-Awsat, ahead of the upcoming Arab Summit in Tunisia end of this month, Zaki said: “Dialogue with these two countries is suspended until the formation of a united Arab stance towards them and their readiness to change their political approach based on the principle of good neighborliness, the respect of sovereignty, non-interference and stopping terrorism support.”

The Arab situation has suffered for many years from many problems due to crises in certain countries, Zaki noted, adding that such situation had negative repercussions on the stability of the region and the decline of the process of development and political cohesion within the Arab body.

“The convening of the Arab League summit will witness talks on whether or not it will be the most important opportunity to restore Arab cohesion and deal with the existing political crises; and we hope that this summit will see serious work and all indicators confirm this already,” he stated.

Asked about the repercussions of the US decisions on Jerusalem and the Golan Heights on the summit, Zaki said: “I am looking forward to a real and in-depth discussion at the level of the Arab foreign ministers at the Tunis summit on this subject…The Golan Heights is considered occupied territory… and the Secretary-General warned of the seriousness of this action on the US mediation in the peace process in the Middle East as a whole.”

As for the question of the return of Syria to the Arab League, the assistant secretary-general emphasized that if the Syrian regime was keen on Syria’s unity, “it must take several positions that would strengthen its role and show that it does not stand alone in resolving its crises.”

“This direction does not exist so far,” he stressed.

As for the participation of the Arab League in the gathering of the Libyan national dialogue, Zaki underlined that this file concerned the Libyans only.

“The role of the Arab League is to assist, support and encourage the political process led by the United Nations. In this regard, it will host in Tunis on the eve of the summit, the quartet meeting on Libya, with the participation of the United Nations, the African Union and the European Union.”

On the latest developments in Algeria, Zaki stressed that the country did not ask for any support from the Arab League.

“Algeria did not ask, and the Arab League does not interfere because what is happening is an Algerian issue. We are monitoring the situation, trusting the wisdom of the Algerians, and supporting the stability of all the Arab countries,” he remarked.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.